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In liver, most genes are expressed with a porto-central gradient. The transcription factor hepatic
nuclear-factor4(HNF4)isassociatedwith12%ofthegenesinadultliver,butitsinvolvement
inzonationofgeneexpressionhasnotbeeninvestigated.AputativeHNF4-responseelementin
the upstream enhancer of glutamine synthetase (GS), an exclusively pericentral enzyme, was
protected against DNase-I and interacted with a protein that is recognized by HNF4-speciﬁc
antiserum. Chromatin-immunoprecipitation assays of HNF4-deﬁcient (H4LivKO) and con-
trol (H4Flox) livers with HNF4 antiserum precipitated the GS upstream enhancer DNA only
from H4Flox liver. Identical results were obtained with a histone-deacetylase1 (HDAC1) anti-
body, but antibodies against HDAC3, SMRT and SHP did not precipitate the GS upstream
enhancer. In H4Flox liver, GS, ornithine aminotransferase (OAT) and thyroid hormone-recep-
tor 1 (TR1) were exclusively expressed in pericentral hepatocytes. In H4LivKO liver, this
pericentral expression remained unaffected, but the genes were additionally expressed in the
periportal hepatocytes, albeit at a lower level. The expression of the periportal enzyme phos-
phoenolpyruvate carboxykinase had declined in HNF4-deﬁcient hepatocytes. GS-negative
cells, which were present as single, large hepatocytes or as groups of small cells near portal veins,
did express HNF4. Clusters of very small GS- and HNF4-negative, and PCNA- and OV6-
positive cells near portal veins were contiguous with streaks of brightly HNF4-positive, OV6-,
PCNA-, and PEPCK-dim cells. Conclusion: Our ﬁndings show that HNF4 suppresses the
expression of pericentral proteins in periportal hepatocytes, possibly via a HDAC1-mediated
mechanism. Furthermore, we show that HNF4deﬁciency induces foci of regenerating hepato-
cytes. (HEPATOLOGY 2007;45:433-444.)
T
he development and maintenance of liver archi-
tecture and function is regulated by liver-en-
riched transcription factors.1 One of these,
hepatic nuclear factor 4 (HNF4; NR2A1) is expressed
at high levels in liver, kidney, intestine, and pancreas2,3
and binds to the promoter of 12% of genes that are ex-
pressed in adult liver.4 HNF4 is an orphan member of
the nuclear-receptor superfamily.2 Depending on chain
length and degree of saturation,5 fatty acyl-coenzyme A
thioesters may act as agonistic or antagonistic factors, but
whether or not these thioesters function as ligands re-
mains unsettled.2,6-8
TranscriptionalregulationbyHNF4isaccomplished
by interactions with coactivator or corepressor mediators
(e.g., GRIP1, SRC-1, CBP/p300, SMRT).6,7,9,10 The re-
sulting coactivator or corepressor complexes have intrin-
sic histone acetyltransferase (HAT) and histone
deacetylase (HDAC) activity, respectively. Histone mod-
iﬁcations play an important role in the regulation of the
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433accessibility of the DNA. They can promote an open
chromatin structure, in which the DNA template is ac-
cessible for transcription factors, or facilitate chromatin
condensation, leading to a transcriptionally nonpermis-
sive state.11 During embryonic development HNF4
supports gastrulation by regulating genes that are ex-
pressedintheextraembryonicvisceralendoderm.3Inliver
organogenesis and regeneration, HNF4 directs hepato-
blasts differentiation to hepatocytes and controls the for-
mation of the liver parenchyma.12-15
The adult mammalian liver is actively involved in ami-
no-acid, carbohydrate and lipid metabolism, xenobiotic
detoxiﬁcation,andtheproductionofbileacidsandserum
proteins. To maintain homeostasis, the complementary
routes of the metabolic functions of the liver (e.g., glu-
coneogenesis and glycolysis, lipid oxidation and lipogen-
esis) are heterogeneously expressed.16 Amino-acid
metabolism,gluconeogenesis,lipidoxidation,energyme-
tabolismandglycogensynthesisfromlactatetakeplacein
the upstream, periportal hepatocytes. On the other hand,
glycolysis, lipogenesis, cytochrome P450-dependent de-
toxiﬁcation and glycogen synthesis from glucose are lo-
cated in the downstream, pericentral hepatocytes.
Ammonia detoxiﬁcation by the urea cycle is found in a
wide periportal zone, whereas its detoxiﬁcation via glu-
tamine biosynthesis is found exclusively in a narrow peri-
central zone of hepatocytes.16 We have extensively
investigated the regulation of expression of GS as a para-
digm for pericentral gene expression. Previous in vitro
experiments have shown that interactions between the
upstream enhancer located at 2.5 kb and several in-
tronic regulatory elements determine the degree of acti-
vation of the GS promoter.17-19 However, the in vivo
mechanism regulating pericentral GS expression has re-
mained unclear.
HNF4 has been reported to be involved in the regu-
lation of both periportally expressed genes (e.g., the
gluconeogenic enzymes PEPCK20and glucose-6-phos-
phatase,21 and the urea cycle enzyme OTC22), and peri-
centrally expressed genes (e.g., some cytochrome P-450
genes, including Cyp7 and UDP-glucuronyltrans-
ferase,23,24 and apolipoprotein E25). In the course of our
analysis of the regulation of GS, we noticed the presence
of a potential HNF4-response element in the GS up-
streamenhancer.ThisstudyexplorestheregulationofGS
expression through this upstream enhancer element and
shows that HNF4 binds to the GS upstream enhancer.
When we extended the study to HNF4-deﬁcient livers,
we observed that HNF4 not only stimulates expression
of periportal genes (PEPCK), but also suppresses the ex-
pression of GS and several other pericentrally expressed
genes in the periportal areas, suggesting that these genes
share a common regulatory mechanism. In addition, we




(HNF4ﬂ/ﬂ;AlbCre/, designated H4LivKO) and its
control (HNF4ﬂ/ﬂ;AlbCre/, designated H4Flox) were
described previously.13 Albumin-cre mice express cre re-
combinase in their hepatocytes from neonatal day 10 on-
ward.26
Sequence Analysis. The GS upstream enhancer is a
244bp long element located 2.5kb relative to the tran-
scription-startsite.17Thissequencewasanalyzedfortran-
scription factor-binding sites with MatInspector
Professional (release 4.3, Genomatix Software, Geno-
matix, Munchen, Germany), which is based on the Mat-
Inspector program,27 using the vertebrate matrix library
and optimized thresholds.
Preparation of Protein Extracts. Nuclear extracts
from rat livers were prepared as described.28 Brieﬂy, livers
were homogenized in 2 M sucrose and nuclei were puri-
ﬁed througha2Msucrose cushion. Chromatin was pre-
cipitated in 0.4 M (NH4)2SO4. Nuclear proteins were
precipitated from the resulting supernatant by increasing
the (NH4)2SO4 concentration to 2.2 M, followed by di-
alysis against 40 mM KCl.
In Vitro Footprinting. The DNA matrix was pro-
duced by PCR, using a [32P]dATP-radiolabelled oligo-
nucleotideprimer,andpuriﬁedona2%MS8agarosegel.
The F1 and R1 primer set used for footprinting is de-
picted in Fig. 1. The reaction mixture contained 20 go f
rat liver nuclear extract or BSA diluted in 15 l buffer
containing25mMHEPESpH7.6,40mMKCl,50mM
(NH4)2SO4,20%glycerol,0.1mMEDTA,1mMDTT.
After addition of 12.5 l buffer containing 90 mM
HEPES pH 7.6, 144 mM KCl, 24 mM MgCl2, 24%
glycerol, 0.36 mM EDTA, 3.6 mM DTT and 10 gd s
Fig. 1. Sequence of the GS upstream enhancer element. The F1-R1
probe used for the in vitro footprinting experiments was prepared using
the F1 and R1 oligonucleotides. Arrows marked by “HNF4” identify the
oligonucleotides used in the electrophoretic mobility shift assay. The
consensus binding site for the HNF4 is printed in bold.
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utes, followed by the addition of 2 L probe (20,000
cpm). After incubation on ice for 20 minutes, 0, 0.5, 1.0,
5.0 or 10.0 g of DNase I was added for exactly 2 addi-
tional minutes. The reactions were terminated by addi-
tion of 50 l 50 mM EDTA pH 8.0, 0.2% SDS, 100
g/ml tRNA, 500 g/ml proteinase K and incubated at
50°Cfor30minutes.Sampleswerephenol-extractedand
ethanol-precipitated. The pellets of the radiolabelled
DNA were dissolved in 4 l loading buffer (95% form-
amide,10mMEDTA,0.05%bromophenolblue,0.05%
xylene cyanol), of which 2 l was separated on a denatur-
ing6%polyacrylamidegel.Radioactivitywascollectedon
a storage phosphor screen and visualized using a Storm
680 phosphorimager (Molecular Dynamics, Sunnyvale,
CA). The results were analyzed with ImageQuant (ver-
sion 5.0 software).
Electrophoretic Mobility Shift Assay. Double-
stranded probes were designed on basis of the rat GS
upstream enhancer sequence. Probes for the intact and




[32P]dATP using the Klenow enzyme and puriﬁed on a
Sephadex G50. Nuclear extract (5 g) was pre-incubated
on ice for 10 minutes in the presence of 20 mM HEPES
pH7.6,60mMKCl,12%glycerol,1mMEDTA,1mM
DTT, 1 mM spermidine, 1 g ds poly(dIdC). After ad-
dition of 1 l probe (20,000 cpm), speciﬁc complexes
were allowed to form on ice for 20 minutes. To perform
competition experiments, unlabelled oligonucleotides
were added to the reaction mixture in 10, 100 and 1,000-
fold excess. The supershift analysis employed 1 l of goat
anti-human HNF4 antibody (Santa Cruz Biotechnol-
ogy, CA). Unlabelled competitors or antibodies were in-
cubated with the basic reaction mixture for an additional
10 minutes. Samples were loaded onto a native 6% poly-
acrylamide gel and run at 10 V/cm. The radioactivity on
the dried gels was visualized and analyzed as described for
in vitro footprinting.
Chromatin Immunoprecipitation. In order to
crosslink the transcription complexes in their native nuclear
environment, the livers of anaesthetized mice were perfused
via the portal vein with, successively, PBS, 1% formalde-
hyde, and 0.125 M glycine for 10 minutes each. Cross-
linked nuclei were puriﬁed by centrifugation through a
sucrose gradient as described.29 Immunoprecipitations and
washings were performed as described.30,31 Anti-HDAC1
waspurchasedfromUpstateBiotechnology(MiltonKeynes,
UK), while anti-SMRT and anti-HDAC3 were from Santa
Cruz Biotechnology. The anti–small heterodimer partner
(anti-SHP) and anti-HNF4 antisera used were described
previously.32,33 Antigen speciﬁcities were conﬁrmed by im-
munoprecipitation-Western-blot assays with cross-linked
chromatin or native nuclear extracts and by competition
experiments. Real-time PCR analysis of GS upstream
nhancer was performed using sense 5-GCAAGCCAGT-
TAAGGAGGGA and antisense 5-CTCCCGTAG-
CCCTCGAATAGprimers(97to77bpand194to214
bp relative to Fig. 1).
Plasmid Construction. Construct 6-bGH contains
modulesoftheGSgenomicDNAthatwereclonedinthe
pSPluc plasmid (Promega). The following fragments
were placed between the HindIII and NcoI sites of the
upstream polylinker: the AﬂIII-AﬂIII upstream enhancer
of GS (2677bp to 2374bp relative to the GS tran-
scription-start site, Fig. 1); the BglII-NcoI fragment con-
taining the GS minimal promoter, ﬁrst exon, 5 and 3
parts of the ﬁrst intron, and the second exon till the be-
ginning of the ORF (Fig. 4A).17,34 The 305bp bovine
growth-hormone polyadenylation sequence (the XbaI–P-
vuII fragment from pcDNA3 (Invitrogen)) was inserted
betweentheXbaIandEcoRVsitesinthepolylinkerdown-
stream of the luciferase ORF.17 Construct 6A-bGH was
made by deleting the AﬂIII-HindIII fragment from the
upstream enhancer of the 6-bGH construct.
The pHNF4 expression plasmid that contained hu-
man HNF4 cDNA was kindly provided by Tanja
Deurholt, AMC Liver Center, University of Amsterdam.
DNA Transfection and Luciferase Assay. Plasmids
used for transfection were isolated using Nucleobond
G-500 columns (Macherey-Nagel). COS-1 cells were
grown to 90% conﬂuence in 6-well culture plates. Poly-
ethylenimine (PEI) transfection was performed as de-
scribed.35Cellsweretransfectedwith2.9gof6-bGHor
6A-bGH, 0.1 g of the Renilla luciferase expression vec-
tor pRL-CMV (Promega), 0.1 go fp H N F 4 , and 0.9
g of plasmid pBS (Promega). Culture medium was re-
freshed24hoursaftertransfection.Thecellswerelysed48
hours after transfection in “Passive Lysis Buffer” (Pro-
mega). Both luciferase activities were measured with the
Dual-Luciferase Reporter-Assay System (Promega) and
the AutoLumat plus LB953 luminometer (Berthold
Technologies). The experiment was performed 3 times in
duplicate. Data are presented as average  SEM. A t test
was applied to test HNF4-dependent differences be-
tween 6-bGH and 6A-bGH construct. P less than 0.05
was considered signiﬁcant.
Immunohistochemistry and in Situ Hybridization.
Adult mouse livers were dissected, ﬁxed overnight in 4%
formaldehyde, embedded in parafﬁn and sectioned at 7
mthickness.Thesectionsweredeparafﬁnized,hydrated
in graded alcohols, heated for 10 min at 120°C, 1kPa in
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in Teng-T (10 mM Tris (pH 8.0), 5 mM EDTA, 150
mM NaCl, 0.25% (w/v) gelatin, 0.05% (v/v) Tween-20)
and 10% FCS, and incubated overnight with the ﬁrst
antibody. The following antibodies were used: monoclo-
nal anti-rat GS - 1:1,500 (Transduction Laboratories,
Lexington,KY),goatanti-humanHNF4-1:250(Santa
Cruz Biotechnology), rabbit anti-PEPCK - 1:500,20 rab-
bit anti-OAT – 1:2,000,36 rabbit anti-human TR -
1:250,37rabbitanti-Cyp3a41:500(RDI,Concord,MA),
monoclonal OV6 1:250,38,39 monoclonal anti--catenin
1:50 (BD Transduction Laboratories, Bradford, MA),
monoclonal anti-PCNA (PC10) 1:1,000 (Santa Cruz
Biotechnology). Antibody binding was visualized using
ALEXA488- or ALEXA568-labeled (Molecular Probes,
Breda, The Netherlands) or alkaline phosphatase-labeled
antibodies (Sigma-Aldrich, Zwijndrecht, The Nether-
lands). Alkaline phosphatase was visualized using ni-
troblue tetrazolium and 5-bromo-4-choloro-3-indolyl-
phosphate (NBT/BCIP 1:50) as substrates (Roche
Molecular Biochemicals, Woerden, The Netherlands).
For comparisons between H4Flox and H4LivKO sec-
tions staining reactions were performed simultaneously
and for an equal time period. Fluorescence was analyzed
with a BioRad MRC1024 (BioRad, Veenendal, The
Netherlands) confocal laser-scanning microscope or a
Leica DM RA2 microscope (Rijswijk, The Netherlands).
For in situ hybridization, 4 adjacent sections were
stained with digoxigenin (DIG)-labelled complementary
RNAprobesofglutaminesynthetase(GS)andPEPCK.40
Probeboundtothesectionwasimmunologicallydetected
by antidigoxigenin Fab fragment covalently coupled to
alkaline phosphatase. NBT/BCIP was used as chromo-
genic substrate.41
Results
In Vitro Footprinting of the GS Upstream En-
hancer. The binding of transcription factors that are
present in liver nuclear extracts to the upstream enhancer
regionofGSwasvisualizedbyDNaseIfootprinting.The
sequence tested and primers used for generating the
probes are presented in Fig. 1. On both strands, liver
nuclear extract decreased DNase I accessibility to speciﬁc
regions of the DNA template (Fig. 2, nt numbering ac-
cording to Fig. 1). When the upper strand (F1 primer)
was labeled, two footprints and ﬁve hypersensitive bands
were detected (Fig. 2A). When the lower strand was la-
beled (R1 primer), binding of the nuclear extract pro-
tectedfourregionsandincreasedsensitivitytoDNaseIat
two positions (Fig. 2B). The protection from position
105 to 130 in the upper strand overlapped with the pro-
tected area from nt 105 to 125 and a hypersensitivity at
position 105 on the lower strand. The footprint between
nt 150 and 210 on the upper strand corresponded with
the protection between nt 150 and 220, and the hyper-
sensitivity at position 150 on the lower strand. Proteins
causing the hypersensitivities at positions 50, 70 and 85
on the upper strand left a footprint in the region between
nt 50 and 100 on the lower strand. Finally, the hypersen-
sitivities at positions 25 and 35 on the upper strand were
accompaniedbyaprotectionbetweennt20and30onthe
lower strand.
HNF4 Binds to the GS Upstream Enhancer. Ac-
cording to the MatInspector Professional database,27 the
region containing hypersensitivities at position 25 and 35
on the upper strand and a protection between nt 20 and
30 on the lower strand coincides with a potential
HNF4-binding site. Electromobility shift assays, em-
ploying rat-liver nuclear extract, were performed to test
whetherHNF4indeedrecognizestheproposedbinding
site (GGGGGCaAAGCTT). Addition of nuclear extract
to the HNF4 probe resulted in three discrete shifts (Fig.
Fig. 2. In vitro DNase I footprinting. The end-labeled DNA probe was
incubated with bovine serum albumin (BSA) or liver nuclear extract (NE)
for 20 minutes, followed by incubation with 10 g DNase I for 2 minutes
on ice. Footprints are shown on (A) the upper DNA strand and (B) the
lower strand. 10bp: 10bp ladder. Next to each panel, lines and asterisks
mark protected and hypersensitive nucleotides, respectively.
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added to the reaction mixture, the lowest band disap-
pearedandtwonewbandswithalowermobilityappeared
(Fig. 3A, lane 3, bands 4 and 5). Addition of unlabelled
intact probe in 10-, 100- and 1000-fold excess (Fig. 3A,
lanes 4, 5 and 6, respectively) resulted in a gradual disap-
pearance and ﬁnally complete loss of all three shifted
bands, whereas a 1000-fold excess of the mutated HNF4
oligo did not inﬂuence the shifting of the intact HNF4
oligo(Fig.3A,lane7).Nuclearextractandantibodiesdid
Fig. 3. Electrophoretic mobility shift
analysis of HNF4 binding to the GS
upstream enhancer. Liver nuclear ex-
tracts were used to analyze protein
binding to the HNF4 (A) or the HNF4mut
probe (B). Where indicated, nuclear ex-
tract (NE), HNF4 antibody (HNF4 Ab)
or cold competitor probes (HNF4 or
HNF4mut) were added in a 10-fold,
100-fold, or 1000-fold excess. Short
arrows point to the shifting and long
arrows to the supershifting bands.
Fig. 4. Effect of HNF4 co-transfection on GS pro-
moter/enhancer activity in COS-1 cells. (A) Schematic
representation of the 6-bGH and 6A-bGH constructs.
(B) Effect of co-expression of HNF4 on 6-bGH- and
6A-bGH-reporter gene activity into COS-1 cells. Re-
striction sites: A  AﬂIII; H  HindIII; Bg  BglII; B 
BamHI; N  NcoI. Abbreviations: Luc, luciferase open
reading frame; b-GH, bovine growth hormone tran-
scription termination and polyadenylation signal; Tss,
transcription start site. The activities produced by the
studied constructs were normalized with the co-trans-
fected control plasmid pRL-CMV. Reporter gene activity
represents the mean  SEM of 3 independent exper-
iments performed in duplicate. Activity of 6-bGH was
signiﬁcantly different from 6A-bGH with P  0.05.
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3B, lanes 1-3). These results conﬁrmed that HNF4 can
bind to the upstream-enhancer sequence at position
2658 to 2645.
HNF4 Represses GS Expression in Transient
Transfections. To determine whether HNF4 directly
regulatestheexpressionofGS,wetransfectedCOS-1cells
with an HNF4 expression plasmid and either plasmid
6-bGH (containing the putative HNF4-response ele-
ment) or 6A-bGH (lacking the putative HNF4-re-
sponse element). Luciferase reporter-gene activity of
6-bGHamountedto45%ofthatof6A-bGH(P0.05),
showing that HNF4 suppresses GS expression via its
binding site in the GS upstream enhancer element.
HNF4 Binds the GS Upstream Enhancer in Vivo.
To verify the in vivo relevance of HNF4 for the regula-
tion of GS gene expression in the context of chromatin,
weperformedchromatin-immunoprecipitationassaysus-
ing soluble cross-linked liver chromatin from a liver-spe-
ciﬁc HNF4 knockout mouse (H4LivKO) and its
H4Flox control.13 As shown in Fig. 5, an antibody raised
against HNF4 could efﬁciently immunoprecipitate GS
upstream-enhancer DNA, when wild type liver (H4Flox)
was used, whereas this was not the case for H4LivKO
liver.Additionally,inH4Floxliver,wecoulddemonstrate
thepresenceofhistonedeacetylase1(HDAC1)ontheGS
upstream enhancer, which was lost in H4LivKO liver
(Fig. 5). In contrast, antibodies directed against SMRT,
HDAC3 and SHP did not precipitate the GS upstream
enhancer (not shown). These ﬁndings indicate that the
regulation of GS expression in hepatocytes involves
HNF4-dependent recruitment of HDAC1-containing
co-repressor complexes.
Periportal Expression of GS in H4LivKO Livers.
To further demonstrate how HNF4 regulates GS ex-
pression in vivo, in situ hybridization was performed on
H4Flox and H4LivKO liver. The histology of these livers
has been reported.13 The control H4Flox liver exhibited
the expected pericentral expression of GS mRNA,
whereas no GS mRNA could be detected in periportal
hepatocytes (Fig. 6A). In contrast, GS was present in al-
most all hepatocytes of a H4LivKO liver (Fig. 6C), albeit
that the ectopic periportal expression of GS was less in-
tense than the expression around the central veins. Fur-
thermore, fewer pericentral hepatocytes expressed
high-GS levels in H4LivKO liver than in H4Flox liver
and at a lower level. Immunostaining conﬁrmed the ex-
clusive presence of GS protein in the pericentral hepato-
cytesofcontrolH4Floxliver(Fig.7A,B).Asdescribedfor
GS mRNA, GS protein was present in almost all hepato-
cytes of a H4LivKO liver, albeit that its concentration in
theperiportalhepatocyteswaslowerthanthatintheperi-
central hepatocytes (Fig. 7C). GS-negative cells were ei-
ther present as single, large hepatocytes (Fig. 7E,F) or in
groups near portal veins (Fig. 7D). The presence of GS
mRNA and protein in the periportal zone of the
H4LivKO liver shows that HNF4 normally suppresses
GS expression in periportal hepatocytes, whereas the de-
creasd expression of GS in the pericentral zone of the
H4LivKO liver shows that HNF4 stimulates its expres-
sion in pericentral hepatocytes.
Periportal HNF4-Positive Hepatocytes in H4LivKO
Livers Do Not Express GS. Staining for HNF4 of
control and H4LivKO livers explained the nature of the
GS-negative cells in Fig. 7C-F. In the control liver,
HNF4 showed a nuclear localization in all hepatocytes
(Fig. 8A,B). As expected, H4LivKO liver contained only
few HNF4-positive nuclei (Fig. 8C-F). Immunostain-
ing of serial sections revealed that the HNF4-positive
cellsinH4LivKOliverdidnotcontaindetectablelevelsof
GS,conﬁrmingthatHNF4suppressesGSexpressionin
hepatocytes with a periportal phenotype (compare Fig.
Fig. 5. Recruitment of HNF4 and
HDAC1 to the GS upstream enhancer. Sol-
uble, cross-linked chromatin from livers of
HNF4 lox/lox (H4Flox) and HNF4 lox/lox,
Cre (H4LivKO) mice was subjected to
immunoprecipitation with anti-HNF4
(HNF4), anti-HDAC1 (HDAC1), or non-
immune serum, as indicated (A). The pres-
ence of GS upstream enhancer-containing
DNA in the immunoprecipitates was ana-
lyzed by real-time PCR. The bars represent
average values and standard errors relative
to inputs from 3 experiments. (B) Autora-
diogram of a representative ChIP experi-
ment performed by radioactive PCR.
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ters of very small cells near portal veins that were negative
for both GS and HNF4 (Fig. 7F and Fig. 8F, arrows).
HNF4 Deﬁciency Also Releases Periportal Expres-
sion of OAT and TR. Similar to GS, ornithine ami-
notransferase (OAT) and thyroid hormone receptor 
(TR) are normally expressed in a narrow pericentral
zoneofhepatocytes(Fig.9A,B).AgainsimilartoGS,they
become ectopically expressed in the periportal zone of
H4LivKO livers (Fig. 9D,E). This ﬁnding indicates that
HNF4 is a repressor of periportal expression for several
genes that are normally pericentrally expressed.
Deletion of the HNF4 Gene Impairs Periportal
PEPCK Expression. Periportal PEPCK mRNA (Fig.
6B,D) and protein expression (Fig. 10A-E) in the
H4LivKO liver was weaker than that in the control
H4Flox liver. The comparison with the staining intensity
in the few remaining HNF4-positive hepatocytes un-
derscoresthisargument(Fig.8D-FandFig.10D-F,black
arrows). These observations are in agreement with earlier
ﬁndings that HNF4 stimulates PEPCK expression.42,43
Like HNF4-positive hepatocytes, HNF4-negative pe-
riportal hepatocytes stained stronger for PEPCK than the
corresponding pericentral hepatocytes (Fig. 8D,E and
Fig. 10D,E, white arrows), suggesting that the extracellu-
lar signals that conferred zonation on PEPCK expression
remained intact in H4LivKO livers. Interestingly, the
very small HNF4- and GS-negative periportal hepato-
cytes (Fig. 7F; Fig. 8F) were positive for PEPCK (Fig.
10F). Taken together, these results imply that HNF4
does not inﬂuence porto-central gradient of PEPCK ex-
pression, but strongly affects the level of its expression.
In contrast to PEPCK, carbamoylphosphate syn-
thetase (CPS) is expressed in a very wide periportal area
and is only absent in the GS-positive pericentral hepato-
cytes (Fig. 9C). The pattern of CPS expression was not
disturbed by HNF4 deletion and the hepatocytes
around the central vein remained CPS-negative, indicat-
ing that periportal CPS expression is not regulated by
HNF4(Fig.9F).Additionally,lessintenseCPSstaining
inH4LivKOliverthanincontrolH4Floxliverisinagree-
ment with earlier ﬁndings.22
Fig. 7. GS protein distribution in HNF4-deﬁcient liver. Immunohis-
tochemical staining for the presence of GS in H4Flox (A,B) and H4livKO
(C,F) livers. (B,D,E) are magniﬁcations of the boxed areas in (A) and (C),
whereas (F) is a magniﬁcation of the boxed area in (E). (A) and (C)
present an overview. (D) shows a portal vein with adjacent small,
GS-negative cells (black arrow), whereas (E) shows a central vein.
Double-headed white arrows indicate the porto-central axis (D,E); black
arrows indicate small (D) and very large (F) HNF4-positive cells; black
arrowheads (F) show very small cells near vessel. Bars: 1 mm in (A) and
(C) and 100 m in (B), (D-F).
Fig. 6. GS and PEPCK mRNA distribution in HNF4-deﬁcient liver.
Serial sections were analyzed by in situ hybridization for the presence of
GS (A,C) and PEPCK (B,D) mRNA. (A,B) represent control H4Flox liver,
and (C,D) H4livKO liver. Abbreviations: c, central vein; p, portal vein. Bar:
100 m.
HEPATOLOGY, Vol. 45, No. 2, 2007 STANULOVIC ´ ET AL. 439Fig. 8. Periportal HNF4-positive hepatocytes in H4LivKO livers do not
express GS. Immunohistochemical staining for the presence of HNF4 in
H4Flox (A,B) and H4livKO (C-F) livers. The panels are serial sections of
the images shown in Fig. 7. Note that large HNF4-positive cells are not
necessarily GS-negative (E), but that small HNF4-positive cells in the
periportal zone are all GS-negative (D). Black arrow indicates HNF4-
positive cells (D,F) and black arrowheads show very small, HNF4-
negative cells (F). Bars: 1 mm in (A) and (C) and 100 m in (B), (D-F).
Fig. 9. OAT, TR, and CPS distribution in
HNF4-deﬁcient liver. Immunohistochemical
staining for the presence of ornithine aminotrans-
ferase (A,D), thyroid-hormone receptor 1 (B,E)
and carbamoylphosphate synthetase I (C) and (F)
in H4Flox (A-C) and H4livKO (D-F) livers. Bar: 1
mm.
Fig. 10. Deletion of the HNF4 gene impairs PEPCK expression. Immuno-
histochemical staining for the presence of phosphoenolpyruvate carboxykinase in
H4Flox(A,B)andH4livKO(C-F)livers.Thepanelsareserialsectionsoftheimages
shown in Fig. 7. Note that the zonation of PEPCK expression that is seen in control
liver is maintained in H4livKO liver (double-headed white arrow indicates porto-
central gradient in (E). Intense PEPCK expression is only seen in large, HNF4-
positive hepatocytes (cf. Fig. 8) around the portal veins [black arrows in (D) and
(F)]. The HNF4-positive small hepatocytes near the portal vein are also PEPCK-
positive. Black arrowhead shows very small, PEPCK-negative cells. Bars: 1 mm
(A,C) and 100 m in (B,D-F).
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generation. Proliferating-cell nuclear antigen (PCNA)
is a marker for DNA-synthesizing cells.44 In control liver,
some cells adjacent to central veins had weakly positive
nuclei, whereas the rest of the liver was PCNA-negative
(Fig.11A,B).InH4LivKOliver,however,themajorityof
hepatocytes were weakly PCNA-positive (Fig. 11C,D),
suggesting that HNF4 deﬁciency activates the expres-
sion of enzymes involved in DNA synthesis in hepato-
cytes.
The OV-6 antibody, which recognizes cytokeratin-14
and -19, is a marker for oval or hepatocyte-progenitor
cells.38 OV6-positive cells were not detected in control
liver (Fig. 11A,B), but nests of very small (10 m di-
Fig. 11. Expression pattern of GS,
HNF4, OV6, and PCNA in H4LivKO liv-
ers. Immunoﬂuorescent staining of se-
rial sections for the presence of GS,
HNF4, the oval cell marker OV-6, and
PCNA (proliferating-cell nuclear antigen)
in H4Flox [(A) and (B)] and H4livKO [(C)
and (D)] livers. Note normal GS staining
in pericental hepatocytes, the staining
of all hepatocytes for HNF4, the weak
OV-6-staining in cells near the portal
tract and the weakly PCNA-positive nu-
clei near central veins in control liver
[(A) and (B)]. The H4livKO liver shows
persisting pericentral GS expression and
up-regulated GS expression in the rest
of the liver, whereas HNF4 disappeared
except in single, big hepatocytes and in
nests of small, regenerating hepato-
cytes [(C) and (D)] (GS and HNF4).
Increased PCNA and OV-6 expression
suggests DNA synthesis and regenera-
tion in H4KOLiv livers [(C) and (D)]. The
magniﬁcations of the boxed areas in the
OV-6 and PCNA subpanels of (D) show
details of an oval cell-rich area. The
HNF4-negative, OV6-positive and
PCNA-positive cells were contiguous
with streaks of brightly HNF4-positive,
OV6-dim, and PCNA-dim cells [(C) and
(D)]. Bars: 100 and 10 m.
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liver (Fig. 11C,D; Fig. 7F; Fig. 8F; Fig. 10F). In agree-
mentwithearlierﬁndings,12,14,15theseverysmallcellsdid
not express HNF4, but were strongly positive for
PCNA. The HNF4-negative, OV6- and PCNA-posi-
tive cells were contiguous with streaks of brightly
HNF4-positive, OV6- and PCNA-dim cells (Fig.
11C,D). This latter group of HNF4-positive cells
weakly expresses PEPCK, but not GS (Fig. 7D; Fig. 8D;
Fig. 10D). The near absence of OV6 expression, the
bright HNF4 expression and the emerging PEPCK
expression identify these cells as newly differentiated
hepatocytes45,46 that do not (yet) have their HNF4
alleles excised in the knockout mice. Together, these
ﬁndings show that, in contrast to control mice, liver
regeneration from oval cells is activated in HNF4-
deﬁcient mice.
Discussion
HNF4 Suppresses the Expression of a Subset of
Pericentrally Expressed Enzymes in the Periportal
Zone. Our study reports HNF4 binding to the glu-
tamine synthetase upstream enhancer and suppression of
GS expression in the periportal areas. Although we did
not demonstrate HNF4 binding to the TR and OAT
regulatory regions, the similarity in the change of their
expression pattern in the H4LivKO liver suggests that
HNF4 suppresses the expression of these and possibly
other pericentral genes in the periportal region through a
common mechanism. Furthermore, the expression of the
periportal enzyme PEPCK was reduced in the H4LivKO
liver. However, even though expression of GS, OAT and
TR was induced periportally and that of PEPCK re-
duced, HNF4 deletion did not eliminate the porto-cen-
tral gradient of expression of these genes. These ﬁndings
demonstrate that HNF4 enhances the expression of
PEPCK and other periportal genes (e.g., glucose-6-phos-
phatase21) and inhibits the expression of several pericen-
trally expressed genes in the periportal areas.
Northern-andWestern-blotquantiﬁcationofgeneex-
pression in the H4LivKO mouse has revealed altered ex-
pression levels for many liver-speciﬁc genes and an
impaired lipid, protein and glycogen metabolism.13,22
These biochemical studies did not report the residual
HNF4 expression in isolated hepatocytes and periportal
clustersofsmallcells.Inapparentcontrasttoourﬁndings,
it was also reported that GS mRNA levels were not dif-
ferentbetweenHNF4-nullandcontrolmice.22Interest-
ingly, our in situ hybridization showed that the GS
mRNA concentration in the pericentral area was lower in
HNF4 knockout than in control liver. We therefore
conclude that the absence of an overall change in GS
mRNA levels results from an increase in GS mRNA con-
centrationintheperiportalhepatocytesandacompensat-
ing decrease in GS mRNA in the pericentral hepatocytes.
Our data also show that histochemical techniques are a
very useful complement to biochemical techniques, as it
producesexpressiondataatthesingle-celllevelandallows
observation of changes in the distribution of gene expres-
sion. In this respect, the few hepatocytes in which the cre
enzyme did not (yet) excise both HNF4 alleles,13 pro-
vided valuable tissue-intrinsic controls for the effects of
HNF4 deﬁciency on the level of expression of the genes
we studied. Albumin-cre mice express cre recombinase in
their hepatocytes from neonatal day 10 onward.26 How-
ever,ittakesuntiltheanimalsare6weeksoldbeforecreis
expressed throughout the liver and HNF4 in the
H4LivKO liver is decreased to non-detectable levels.13,26
The presence of HNF4 in the small, intensely PCNA-
positive cells can be understood because these cells do not
(yet) express hepatocyte-speciﬁc genes and, hence, do not
express cre.
Although the similarity in the behavior of GS, OAT
and TR in H4LivKO livers suggests a common mecha-
nism of periportal suppression for pericentrally expressed
genes by HNF4, we also observed that Cyp3A4 expres-
sion, which is expressed in a wide pericentral zone, was
not inﬂuenced by the HNF4 deletion (unpublished ob-
servation). Furthermore, another member of the cyto-
chrome P450 family of enzymes, Cyp7a, which, like GS,
OATandTR,ischaracterizedbyaverynarrowpericen-
tral expression pattern,23 is reportedly down-regulated
rather than up-regulated in the HNF4-deﬁcient liv-
ers.13,47 A similar dichotomy appears to exist with respect
to periportal enzymes: some enzymes, like PEPCK and
ornithine transcarbamoylase20,24 are up-regulated by
HNF4,whereasothers,includingCPS,arenotaffected.
These data therefore suggest that HNF4 is not a prime
determinant of the porto-central gradient in gene expres-
sion in the liver, but affects a subgroup of hepatocyte-
speciﬁc genes. In agreement, we noticed that the porto-
central gradient in PEPCK expression was also not
affected by HNF4 deﬁciency.
Mechanism of HNF4-Mediated Periportal Sup-
pression of Gene Expression. HNF4 is present on
approximately 12% of the promoters in liver, 80% of
which are also occupied by RNA polymerase II,4 that is,
are putatively transcribed. The common determinant of
the subgroup of pericentral enzymes, of which expression
in the periportal zone becomes released by HNF4 deﬁ-
ciency, remains to be determined.
Our results show that HNF4 binds GS upstream en-
hancer and suppresses GS expression in the periportal
442 STANULOVIC ´ ET AL. HEPATOLOGY, February 2007region. The most suggestive proof for a direct mechanism
can be found in the immunostainings of H4livKO livers,
inwhichthefewremainingHNF4-positivehepatocytes
in the periportal region do not express GS. These
HNF4-positive hepatocytes show a cell-autonomous
HNF4 effect on GS expression in the periportal region
and do not support an indirect effect due to the overall
changed physiology of the H4livKO liver. HNF4 is
mostly reported to activate transcription,7,48 but it can
also act as a suppressor.6,49 Our ﬁnding that histone
deacetylase 1 (HDAC1) recruitment to the upstream re-
gion of GS is dependent on the presence of HNF4 (Fig.
5) suggests that HNF4-promoted chromatin condensa-
tion could well be a potential mechanism. The orphan
nuclear receptor SHP, which can directly interact with
HDAC1andthehistone-methylatingenzymeG9ameth-
yltransferase,50 has been reported to mediate HNF4 re-
pression of gene expression.49 The co-repressor SMRT
(silencing mediator of retinoid and thyroid receptors),
whichinteractswithhistonedeacetylase3(HDAC3),can
also mediate the HNF4-promoted suppression of gene
expression6,51 and promotes chromatin condensation.52
Since the ChIP assays with SMRT, HDAC3 and SHP
antibodies did not precipitate the GS upstream enhancer,
we propose the HNF4/HDAC1-promoted chromatin
condensation, acting via a yet unidentiﬁed mediator, as a
potential mechanism of the periportal suppression of the
GS gene.
HNF4 Deﬁciency Activates DNA Synthesis and
Induces Liver Regeneration from Oval Cells. We
observed an enhanced expression of the DNA-synthesis
markerPCNA53inallHNF4-deﬁcienthepatocytes.We
also observed a very strong PCNA expression in nests of
very small (10 m) OV6-positive, HNF4-negative
cells near portal tracts that did not express hepatocyte-
speciﬁc enzymes. This phenotype identiﬁes these cells as
oval cells, i.e., hepatocyte-progenitor cells.54 The spatial
continuityofthesecellswithstreaksofOV6-andPCNA-
dim, but brightly HNF4-positive and weakly PEPCK-
positive cells implies a steady production of hepatocytes
from these hepatic stem cells.13,55,56 Altogether, these
ﬁndings reveal the presence of regenerative foci and sug-
gest de-repression of DNA synthesis in HNF4-deﬁcient
hepatocytes.Theregenerativestimulusisunknown,butit
is possible that liver failure underlies the very limited life
span of liver HNF4-deﬁcient mice.13,22
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